Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cohen & Steers

80.32
+0.36000.45%
Post-market: 80.320.00000.00%17:27 EDT
Volume:198.90K
Turnover:15.94M
Market Cap:4.09B
PE:26.26
High:80.89
Open:80.01
Low:79.52
Close:79.96
Loading ...

Cohen & Steers Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
11 Apr

Press Release: NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

Dow Jones
·
10 Apr

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswire
·
10 Apr

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

GlobeNewswire
·
10 Apr

Cohen & Steers, Inc. to Release First Quarter 2025 Results on April 16, 2025

PR Newswire
·
10 Apr

CNS Pharmaceuticals Advances TPI 287 for Glioblastoma

TIPRANKS
·
10 Apr

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

GlobeNewswire
·
09 Apr

Market Chatter: LG CNS Wins KRW130 Billion AI Project from Mirae Asset Life

MT Newswires Live
·
09 Apr

Cohen & Steers Reports Sequential Decline in March Preliminary AUM

MT Newswires Live
·
09 Apr

Cohen & Steers reports preliminary AUM of $87.6B as of March 31

TIPRANKS
·
09 Apr

BRIEF-Cohen & Steers Announces Preliminary Assets Under Management, Net Flows For March

Reuters
·
09 Apr

Cohen & Steers Inc - Reports Preliminary Aum of $87.6 Billion as of March 31, 2025

THOMSON REUTERS
·
09 Apr

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for March 2025

THOMSON REUTERS
·
09 Apr

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for March 2025

PR Newswire
·
09 Apr

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

GlobeNewswire
·
09 Apr

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

GlobeNewswire
·
09 Apr

Cerevance Presents Positive Results from Phase 1 Study of CVN293 at American Academy of Neurology 2025 Annual Meeting

GlobeNewswire
·
08 Apr

Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies

GlobeNewswire
·
08 Apr

Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson’s Disease

Business Wire
·
07 Apr

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

GlobeNewswire
·
07 Apr